COVID-19 vaccination in Australia

CPD hours:
4

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The COVID-19 pandemic has led to a dramatic loss of human life and has severely affected the global economy and financial markets.

Recurrent waves of COVID-19 infections are expected to circulate for as long as susceptible human hosts are available.

Research indicates that protection from the virus through herd immunity can be achieved more quickly and safely through vaccination rather than natural infection. Vaccines may also produce a greater, more protective, and longer lasting immune protection.

This module provides an overview of COVID-19 and vaccination in the Australian context. It outlines vaccine technology and development, including the assessment process for COVID-19 vaccine candidates.

The module also provides information about the two vaccines provisionally approved for use in Australia, the Pfizer/BioNTech and AstraZeneca/Oxford vaccines, the vaccine with provisional determination, the Novavax vaccine, as well as Australia’s vaccine procurement and rollout strategies.

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

At the end of this module participants will be able to:

  • Discuss the nature of the SARS-CoV-2 structure, infection, and herd immunity.
  • Describe the five main types of vaccines.
  • Understand the conventional vaccine development pathway, and the COVID-19 vaccine development pathway.
  • Describe the Australian Government’s vaccine procurement strategy.
  • Discuss key information about the Pfizer/BioNTech, AstraZeneca/Oxford, and Novavax vaccines.
  • Explain Australia’s national COVID-19 vaccination rollout plan.

At the end of this module participants will be able to:

  • This is learning objective 1.
  • This is learning objective 2.
  • This is learning objective 3.
  • This is learning objective 4.
  • This is learning objective 5.
  • This is learning objective 6.

Other modules to explore

See all modules

Any screen anytime

Fully responsive and optimised for use no matter what the screen size.

User dashboard

Ready access to all of the important functionalities of the LMS at your fingertips.

ePortfolio

All plans, documents and achievements in one single, secure, portal.

Single sign-on

Single sign-on through your website 24 hours a day, 7 days a week.